Erhalte eine Antwort von diesem Arbeitgeber — ein Lebenslauf und ein Anschreiben, die genau auf die Eigenschaften eingehen, die gesucht werden.
Bristol Myers Squibb is seeking a Director, Enterprise Employer Access - Cell Therapy to lead upstream engagement with employer benefit decision networks for CAR-T and future cell/gene therapies. This role focuses on influencing benefit design decisions with employers and consultants before carve-outs or site-of-care requirements are finalized.
The position addresses an access gap as payers shift authority to employers, aiming to protect patient access and drive enterprise value.
Remote - Field - United States
May 13, 2026
$196,390 - $237,982/year
Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us .
SUMMARY:
The Director, Enterprise Employer Access - Cell Therapy is responsible for establishing early, upstream engagement across the employer benefit decision landscape to influence benefit design decisions for CAR-T and future cell and gene therapies both directly with employers and indirectly through the consultants, TPAs, and specialty vendors that shape those decisions, before carve-outs, COE mandates, or restrictive site-of-care requirements are finalized.
This role addresses a critical access gap created by the shift of benefit decision-making authority from payers to employers by proactively engaging the stakeholders who define benefit philosophy upstream. The objective is to protect patient access, preserve provider flexibility, and support long-term enterprise value before coverage parameters are locked in.
As employers increasingly serve as the ultimate decision-makers for high-cost therapies, often delegating execution to intermediaries, downstream payer influence becomes limited or nonexistent once benefit design decisions are finalized. This role ensures the organization is present where and when influence is exerted, shaping benefit strategy early rather than relying on reactive, exception-based access remediation later.
#LI-Field
Compensation Overview:
Field - United States - US: $196,390 - $237,982
The starting compensation range(s) for this role are listed above for a full-time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate takes into account characteristics of the job, such as required skills, where the job is performed, the employee’s work schedule, job-related knowledge, and experience. Final, individual compensation will be decided based on demonstrated experience.
Benefit offerings are subject to the terms and conditions of the applicable plans in effect at the time and may require enrollment. Our benefits include:
Uniquely Interesting Work, Life-changing Careers
With a single vision as inspiring as “Transforming patients’ lives through science™ ”, every BMS employee plays an integral role in work that goes far beyond ordinary. Each of us is empowered to apply our individual talents and unique perspectives in a supportive culture, promoting global participation in clinical trials, while our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
On-site Protocol
BMS has an occupancy structure that determines where an employee is required to conduct their work. This structure includes site-essential, site-by-design, field-based and remote-by-design jobs. The occupancy type that you are assigned is determined by the nature and responsibilities of your role:
Site-essential roles require 100% of shifts onsite at your assigned facility. Site-by-design roles may be eligible for a hybrid work model with at least 50% onsite at your assigned facility. For these roles, onsite presence is considered an essential job function and is critical to collaboration, innovation, productivity, and a positive Company culture. For field-based and remote-by-design roles the ability to physically travel to visit customers, patients or business partners and to attend meetings on behalf of BMS as directed is an essential job function.
Supporting People with Disabilities
BMS is dedicated to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace accommodations/adjustments and ongoing support in their roles. Applicants can request a reasonable workplace accommodation/adjustment prior to accepting a job offer. Equal Employment Opportunity statement.
Candidate Rights
BMS will consider for employment qualified applicants with arrest and conviction records, pursuant to applicable laws in your area.
We will never request payments, financial information, or social security numbers during our application or recruitment process. Learn more about protecting yourself at https://careers.bms.com/fraud-protection .
Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.